End Cash: The amount of cash held by the company for the given period.
Vir Biotechnology, Inc. (VIR) had End Cash of $261.29M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$86.18M |
|
$-615.06M |
|
$2.77M |
|
$83.42M |
|
$770.49M |
|
$-684.31M |
|
$56.11M |
|
$-628.19M |
|
$-628.19M |
|
$-615.12M |
|
$-615.12M |
|
$-615.12M |
|
$-615.12M |
|
$-684.31M |
|
$-673.56M |
|
134.13M |
|
134.13M |
|
$-4.59 |
|
$-4.59 |
|
| Balance Sheet Financials | |
$1.59B |
|
$96.02M |
|
$330.83M |
|
$1.92B |
|
$175.41M |
|
-- |
|
$153.42M |
|
$328.82M |
|
$1.59B |
|
$1.55B |
|
$1.59B |
|
134.78M |
|
| Cash Flow Statement Financials | |
$-778.78M |
|
$164.63M |
|
$7.48M |
|
$867.97M |
|
|
End Cash |
$261.29M |
$-606.68M |
|
$111.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.79% |
|
-794.04% |
|
-794.04% |
|
-781.57% |
|
-728.93% |
|
-713.69% |
|
$-800.36M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-38.68% |
|
-39.67% |
|
-32.05% |
|
-38.68% |
|
$11.80 |
|
$-5.97 |
|
$-5.81 |
|